| |
|
|
|
Seaport Hotel, One Seaport Lane, Boston, MA 02210
September 23-24, 2013
Monday, September 23 Interrogating Cancer Genes with NGS-Based Approaches - Integrated Genomic Data Informs Cancer Treatment
- Solving the "Big Data" Challenge at the Interface of Science and Medicine
- Validation and Clinical Application of a Cancer Genomic Profiling Test Using Next-Generation Sequencing Reveals the Landscape of Clinically Actionable Tumor Alterations
- Individual Patient Full-Genome Cancer Profiling for Optimized Treatment Strategies
- Clinical Genomics in a Breast Cancer Multidisciplinary Tumor Board
- Personalized, Precision Lung Cancer Medicine through Integrated Genomic Analysis
Tuesday, September 24 Microarray and Other Cancer Genotyping Technologies - Clinical Molecular Cytogenetics: The Past, the Present, and the Future
- Juxtaposing Genomic Insights of Cancer for Patient Care
- Clinical Cancer Genotyping: Snapshot
- A Novel, Automated Post-Genomic Prostate Cancer Biopsy Test Predictive of Aggressiveness
Data Interpretation - My Cancer Genome - Cancer Genomics Knowledge Resource
- Applying Multiscale Network Modeling to Enable Personalized Cancer Therapy
Moving from Technology to Patient Treatment - Applications of Comprehensive Clinical Genomic Analysis in Solid Tumors: Obstacles and Opportunities
- Cancer Pharmacogenomic Testing, Clinician Adoption and Patient Benefit
- The Promise and Challenges of Personalized Medicine in Cancer Drug Development: An Industry Perspective
The Evolving Role of the Patient - Return of Sequencing Results to Physicians & Patients
- The Patient Perspective
- What Personalized Medicine Means to the Patient from the Patient's Perspective
|
|
|
|
|
|
|
|
Organized by:
|
|
Cambridge Healthtech Institute (CHI) |
|
|
Invited Speakers:
|
|
- Elaine R. Mardis, Ph.D., Professor, Genetics and Molecular Microbiology; Co-Director, The Genome Institute, Washington University School of Medicine at Washington University Medical Center
- John Quackenbush, Ph.D., Professor, Biostatistics and Computational Biology, Cancer Biology Center for Cancer, Dana-Farber Cancer Institute
- Phil Stephens, Ph.D., Vice President, Cancer Genomics, Foundation Medicine
- Raphael Lehrer, Founder and Chief Scientist, GeneKey
- Peter J. Tonellato, Ph.D., Director, Laboratory for Personalized Medicine, Center for Biomedical Informatics, Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School
- Trever Bivona, M.D., Ph.D., Assistant Professor, Medicine/Hematology-Oncology, University of California, San Francisco
- Marilyn M. Li, M.D., Professor & Director, Cancer Genetics Laboratory, Department of Molecular and Human Genetics, Baylor College of Medicine
- Michael E. Berens, Ph.D., Deputy Director, TGen Research Resources; Director, Cancer & Cell Biology Division; Professor, Brain Tumor Unit, TGen
- John Iafrate, M.D., Ph.D., Assistant Professor, Pathology, Harvard Medical School; Assistant Pathologist, Massachusetts General Hospital
- Peter Blume-Jensen, M.D., Ph.D., CSO, Metamark Genetics, Inc.
- Christine Micheel, Ph.D., Research Assistant Professor, Medicine, Vanderbilt-Ingram Cancer Center; Managing Editor, MyCancerGenome.org
- Joel Dudley, Ph.D., Assistant Professor, Genetics and Genomic Sciences; Director, Biomedical Informatics, Mount Sinai School of Medicine
- Scott M. Kahn, Ph.D., Adjunct Associate Research Scientist, Department of Urology; Member, Herbert Irving Comprehensive Cancer Center, Columbia University; Chairman, Biomarkers Council, International Cancer Advocacy Network (ICAN)
- Vincent A. Miller, M.D., Senior Vice President, Clinical Development, Foundation Medicine
- Lynn Dressler, Ph.D., Director, Personalized Medicine, Fullerton Genetics Center, Mission Health
- Joseph Pearlberg, M.D., Ph.D., Senior Medical Director, Oncology, Sanofi
- Cinnamon S. Bloss, Ph.D., Director, Social Sciences & Bioethics, Assistant Professor, Scripps Translational Science Institute
- Kim Ryan, Director, Patient Information Services, Fight Colorectal Cancer
- Kim Norris, President, Lung Cancer Foundation of America
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
August 23, 2013
|
|
|
|
|
|
|
|
Registration:
|
|
Register Now
|
|
|
E-mail:
|
|
kwaterman@healthtech.com
|
|
|
|
|
|
|
|
|